Blood assay of anti-tissue transglutaminase (anti-tTG) IgA is the first-line test for the diagnosis of celiac disease in patients without IgA deficiency with a sensitivity of 89–93% and a specificity of 98% (57–59). This evidence concerns the gene TGM2 and selective IgA deficiency disease.